Health Care & Life Sciences » Pharmaceuticals | GreenPeptide Co. Ltd.

GreenPeptide Co. Ltd. | Mutual Funds

Mutual Funds that own GreenPeptide Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Siemens Global Growth
98,300
0.24%
3,200
0.22%
04/30/2018
SPDR S&P World (ex-US) ETF
40,700
0.1%
200
0%
09/06/2018
GO UCITS ETF Solutions Plc - FTSE 100 Super Short Strat. (2x)
0
0%
-28,800
0%
02/28/2018

About GreenPeptide Co.

View Profile
Address
Fukuoka Bio Incubation Center 402
Kurume Fukuoka 839
Japan
Employees -
Website http://www.brightpathbio.com
Updated 07/08/2019
BrightPath Biotherapeutics Co., Ltd. engages in the drug development business. It focuses on the development of cancer immunotherapies. Its product candidates are based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens.